Mixed Connective Tissue Disease (MCTD) is an autoimmune disorder where the immune system attacks healthy cells. Learn about the causes, symptoms, and treatment options for this condition today.

Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The ...

EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex ® CTDplus multiplex assay. The multiplex assay enables a syndromic approach ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of rheumatoid arthritis (RA) and connective tissue diseases (CTD) for healthcare providers. Its unique ...

In 119 patients (23.5 per cent of the entire group with Hashimoto's thyroiditis) symptoms and findings diagnostic or suggestive of a systemic connective-tissue disorder were obtained ().Twenty ...

PR Newswire EYSINS, Switzerland, Feb. 3, 2025 EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex® CTDplus multiplex assay.

AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) multiplex microarray PR Newswire EYSINS, Switzerland, April 3, 2025 ...

/PRNewswire/ -- Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® ...

EYSINS, Switzerland, April 3, 2025 /PRNewswire/ -- Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® ...